Tandem Diabetes Care, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
Tandem Diabetes Care, Inc. (TNDM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $3.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-19
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $3.95M, a 31.53% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $5.77M, a 61.27% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $14.90M, a 553.11% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $2.28M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-31 | $3.95M 10-K · filed 2026-02-19 |
| 2024-12-31 | $5.77M 10-K · filed 2026-02-19 |
| 2023-12-31 | $14.90M 10-K · filed 2026-02-19 |
| 2022-12-31 | $2.28M 10-K · filed 2025-02-26 |
| 2021-12-31 | -$7.61M 10-K · filed 2024-02-21 |
| 2020-12-31 | -$18.31M 10-K · filed 2023-02-22 |
| 2019-12-31 | -$8.97M 10-K · filed 2022-02-22 |
| 2018-12-31 | $1.36M 10-K · filed 2021-02-24 |
| 2017-12-31 | $3.21M 10-K · filed 2020-02-24 |
| 2016-12-31 | $1.69M 10-K · filed 2019-02-26 |
| 2015-12-31 | $1.90M 10-K · filed 2018-03-01 |
| 2014-12-31 | $1.97M 10-K · filed 2017-03-08 |
| 2013-12-31 | $831.00K 10-K · filed 2016-02-24 |
| 2012-12-31 | $82.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |